These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19368038)

  • 41. [Adolescents who have tried illicit drugs and experienced psychiatric symptoms seldom seek professional help. A pilot study of 18-year old high school students in an urban district].
    Gunnarsson M; Fahlke C; Balldin J
    Lakartidningen; 2004 Apr; 101(14):1280-2. PubMed ID: 15101214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles (see pages 153-174).
    Sparenborg S; Vocci F; Zukin S
    Drug Alcohol Depend; 1997 Dec; 48(3):149-51. PubMed ID: 9449012
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers.
    Vansickel AR; Fillmorex MT; Hays LR; Rush CR
    Am J Drug Alcohol Abuse; 2008; 34(3):293-305. PubMed ID: 18428072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.
    Heidbreder CA; Hagan JJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.
    Brodie JD; Figueroa E; Laska EM; Dewey SL
    Synapse; 2005 Feb; 55(2):122-5. PubMed ID: 15543630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circumspectives: The Replacements.
    Heilig M; Carlezon WA
    Neuropsychopharmacology; 2015 Jul; 40(8):1813-4. PubMed ID: 26068571
    [No Abstract]   [Full Text] [Related]  

  • 47. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.
    Kiluk BD; Carroll KM; Duhig A; Falk DE; Kampman K; Lai S; Litten RZ; McCann DJ; Montoya ID; Preston KL; Skolnick P; Weisner C; Woody G; Chandler R; Detke MJ; Dunn K; Dworkin RH; Fertig J; Gewandter J; Moeller FG; Ramey T; Ryan M; Silverman K; Strain EC
    Drug Alcohol Depend; 2016 Jan; 158():1-7. PubMed ID: 26652899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Practice parameter for the use of stimulant medications.
    Ravenel SD
    J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1146-7; author reply 1147. PubMed ID: 12364835
    [No Abstract]   [Full Text] [Related]  

  • 49. Kappa opioids as potential treatments for stimulant dependence.
    Prisinzano TE; Tidgewell K; Harding WW
    AAPS J; 2005 Oct; 7(3):E592-9. PubMed ID: 16353938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies.
    Fischer B; Blanken P; Da Silveira D; Gallassi A; Goldner EM; Rehm J; Tyndall M; Wood E
    Int J Drug Policy; 2015 Apr; 26(4):352-63. PubMed ID: 25662894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.
    Rothman RB; Blough BE; Baumann MH
    AAPS J; 2007 Jan; 9(1):E1-10. PubMed ID: 17408232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Addiction to stimulants.
    Bell DS
    Med J Aust; 1967 Jan; 1(2):41-5. PubMed ID: 4381056
    [No Abstract]   [Full Text] [Related]  

  • 53. Speed, cocaine, and other psychostimulants death rates.
    Gold MS; Graham NA; Kobeissy FH; Pepine CJ; Goldberger BA
    Am J Cardiol; 2007 Oct; 100(7):1184. PubMed ID: 17884386
    [No Abstract]   [Full Text] [Related]  

  • 54. Behavioral therapies for drug abuse.
    Carroll KM; Onken LS
    Am J Psychiatry; 2005 Aug; 162(8):1452-60. PubMed ID: 16055766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
    Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ubiquitous Dopamine Deficit Hypotheses in Cocaine Use Disorder Lack Support.
    Leyton M
    Am J Psychiatry; 2021 May; 178(5):469. PubMed ID: 33979542
    [No Abstract]   [Full Text] [Related]  

  • 57. The combination of metyrapone and oxazepam for the treatment of cocaine and other drug addictions.
    Goeders NE; Guerin GF; Schmoutz CD
    Adv Pharmacol; 2014; 69():419-79. PubMed ID: 24484984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimulant abuse treatment as HIV prevention.
    Shoptaw S; Reback CJ; Frosch DL; Rawson RA
    J Addict Dis; 1998; 17(4):19-32. PubMed ID: 9848029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccines against drug abuse.
    Shen XY; Orson FM; Kosten TR
    Clin Pharmacol Ther; 2012 Jan; 91(1):60-70. PubMed ID: 22130115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholinesterase inhibitors might alleviate methamphetamine-induced delusions, hallucinations and cognitive impairment, while reducing craving and addiction.
    Alisky JM
    World J Biol Psychiatry; 2006; 7(4):269. PubMed ID: 17071550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.